tipo
- journal article
Obinutuzumab short-duration infusion (SDI) in previously untreated advanced follicular lymphoma: Results from the end of induction analysis of the phase IV GAZELLE study.
Documento
- Visão geral
- Identidade
- Informação adicional documento
- Outro
- Ver todos